Artículos del autor

solaci

Institutional News

Save the date Only 2 months for the SOLACI-SOCIME 2022 Congress

August is the month in which we meet again to continue developing interventional cardiology on the continent. Discover...
solaci -
Other

A Nod to Catheter-Guided Thrombolysis in Pulmonary Thromboembolism

Pulmonary thromboembolism (PTE) is the third most frequent cardiovascular disease, with an increasing prevalence over time. The...
solaci -
Mitral valve

Post-MitraClip Mitral Valve Stenosis: Bad Prognosis

The EVEREST II trial has shown the MitraClip has similar mortality rate to that of surgery and,...
solaci -
Structural heart disease

New-Generation ACURATE Neo2

Transcatheter aortic valve replacement (TAVR) is a therapeutical option for patients with symptomatic severe aortic stenosis. Current...
solaci -
Mitral valve

MitraClip Reduces Renal Function Deterioration

Severe mitral regurgitation is associated to cardiac failure and hospitalization and over time is accompanied by kidney...
solaci -
Structural heart disease

TAVR: If Not Transfemoral, We Should Consider Transcaval Access

Transcatheter aortic valve replacement (TAVR) through transfemoral access has already proven its great benefits, but this access...
solaci -
Coronary disease

Revascularization Using DES in Infrapopliteal Disease: Meta-Analysis and Change of Paradigm?

Peripheral vascular disease (PVD) has been under-studied and under-recognized in comparison with ischemic heart disease and stroke,...
solaci -
Other

EuroPCR 2022 | CLASP TR Study: Promising Results of Endovascular Intervention of Tricuspid Regurgitation

At present, we are well aware of the rise in mortality caused by severe tricuspid regurgitation (TR)....
solaci -